Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.240
-0.110 (-4.68%)
At close: Oct 26, 2026, 4:00 PM EDT
2.238
-0.002 (-0.08%)
After-hours: Oct 26, 2026, 4:53 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $233.82 million as of October 26, 2026. It is the 19,419th most valuable company in the world and the 3,389th biggest in the United States. Its market cap has decreased by 35.11% in one year.
Market Cap
233.82M
Enterprise Value
82.51M
1-Year Change
-35.11%
Global Rank
Country Rank
#3,389 United States
Category
ChartMarket Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $233.82M, an increase of 106.22%. That is a compound annual growth rate of 11.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 233.82M | -28.30% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 252.91M |
| Fate Therapeutics | 252.82M |
| Abeona Therapeutics | 251.61M |
| Rocket Pharmaceuticals | 251.38M |
| Ocugen | 250.84M |
| Cabaletta Bio | 249.23M |
| Clinuvel Pharmaceuticals | 248.63M |
| Bicycle Therapeutics | 248.47M |